Neurodevelopmental role for VGLUT2 in pyramidal neuron plasticity, dendritic refinement, and in spatial learning

Journal of Neuroscience

Volumn 32, Issue 45, 2012, Pages 15886-15901

  He, Hongbo ^a,d   Mahnke, Amanda H ^c   Doyle, Sukhjeevan ^a   Fan, Ni ^a   Wang, Chih Chieh ^c   Hall, Benjamin J ^c   Tang, Ya Ping ^b   Inglis, Fiona M ^c   Chen, Chu ^a   Erickson, Jeffrey D ^a  

^a Neuroscience Center   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Tulane University   (United States)

^d GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SPINOPHILIN; VESICULAR GLUTAMATE TRANSPORTER 1; VESICULAR GLUTAMATE TRANSPORTER 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CELL MATURATION; CONTROLLED STUDY; DENDRITIC SPINE; ENDOPHENOTYPE; EVOKED RESPONSE; FEMALE; GENE INACTIVATION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; IMMUNOHISTOCHEMISTRY; KARYOTYPING; LEARNING; MALE; MEMORY DISORDER; MOUSE; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROTRANSMISSION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; SYNAPSE; WESTERN BLOTTING;

ANIMALS; DENDRITES; DENDRITIC SPINES; HIPPOCAMPUS; LEARNING; MICE; MICE, KNOCKOUT; MICROFILAMENT PROTEINS; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; PYRAMIDAL CELLS; SPACE PERCEPTION; SPATIAL BEHAVIOR; SYNAPSES; VESICULAR GLUTAMATE TRANSPORT PROTEIN 1; VESICULAR GLUTAMATE TRANSPORT PROTEIN 2;

EID: 84868578255     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4505-11.2012     Document Type: Article

References (115)

1. Amitai Y (2001) Thalamocortical synaptic connections: efficacy, modulation, inhibition and plasticity. Rev Neurosci 12:159-173. CrossRef Medline
2. Asaka Y, Jugloff DG, Zhang L, Eubanks JH, Fitzsimonds RM (2006) Hip-pocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome. Neurobiol Dis 21:217-227. CrossRef Medline
3. Atkinson L, Batten TF, Moores TS, Varoqui H, Erickson JD, Deuchars J (2004) Differential co-localisation of the P2X7 receptor subunit with vesicular glutamate transporters VGLUT1 and VGLUT2 in rat CNS. Neu-roscience 123:761-768. CrossRef Medline
4. Balschun D, Moechars D, Callaerts-Vegh Z, Vermaercke B, Van Acker N, Andries L, D'Hooge R (2010) Vesicular glutamate transporter VGLUT1 has a role in hippocampal long-term potentiation and spatial reversal learning. Cereb Cortex 20:684-693. CrossRef Medline
5. Bergeron R, Meyer TM, Coyle JT, Greene RW (1998) Modulation of N-methyl-D-aspartate receptor function by glycine transport. Proc Natl Acad Sci U S A 95:15730-15734. CrossRef Medline
6. Bolshakov VY, Siegelbaum SA (1995) Regulation of hippocampal transmitter release during development and long-term potentiation. Science 269: 1730-1734. CrossRef Medline
7. Boulland JL, Qureshi T, Seal RP, Rafiki A, Gundersen V, Bergersen LH, Fremeau RT Jr, Edwards RH, Storm-Mathisen J, Chaudhry FA (2004) Expression of the vesicular glutamate transporters during development indicates the widespread corelease ofmultiple neurotransmitters. J Comp Neurol 480:264-280. CrossRef Medline
8. Boulland JL, Jenstad M, Boekel AJ, Wouterlood FG, Edwards RH, Storm-Mathisen J, Chaudhry FA (2009) Vesicular glutamate and GABA transporters sort to distinct sets of vesicles in a population of presynaptic terminals. Cereb Cortex 19:241-248. CrossRef Medline
9. Broadbelt K, Byne W, Jones LB (2002) Evidence for a decrease in basilar dendrites of pyramidal cells in schizophrenic medial prefrontal cortex. Schizophr Res 58:75-81. CrossRef Medline
10. Brun VH, Otnass MK, Molden S, Steffenach HA, Witter MP, Moser MB, Moser EI (2002) Place cells and place recognition maintained by direct entorhinal-hippocampal circuitry. Science 296:2243-2246. CrossRef Medline
11. Cain DP (1998) Testing the NMDA, long-term potentiation, and cholin-ergic hypothesis of spatial learning. Neurosci Biobehav Rev 22:181-193. CrossRef Medline
12. Carlsson ML (1998) Hypothesis: is infantile autism a hypoglutamatergic disorder? Relevance of glutamate - serotonin interactions for pharmaco-therapy. J Neural Transm 105:525-535. CrossRef Medline
13. Chao HT, Zoghbi HY, Rosenmund C (2007) MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 56:58-65. CrossRef Medline
14. Choudhury PR, Lahiri S, Rajamma U (2012) Glutamate mediated signaling in the pathophysiology of autism spectrum disorders. Pharmacol Biochem Behav 100:841-849. CrossRef Medline
15. Cline H, Haas K (2008) The regulation of dendritic arbor development and plasticity by glutamatergic synaptic input: a review of the synaptotrophic hypothesis. J Physiol 586:1509-1517. CrossRef Medline
16. Cline HT (2001) Dendritic arbor development and synaptogenesis. Curr Opin Neurobiol 11:118-126. CrossRef Medline
17. Coyle JT, Tsai G (2004) The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia. Psychopharmacology (Berl) 174:32-38. CrossRef Medline
18. Dani VS, Chang Q, Maffei A, Turrigiano GG, Jaenisch R, Nelson SB (2005) REduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc Natl Acad Sci U S A 102:12560-12565. CrossRef Medline
19. Daniels RW, Collins CA, Gelfand MV, Dant J, Brooks ES, Krantz DE, DiAn-tonio A (2004) Increased expression of the Drosophila vesicular gluta-mate transporter leads to excess glutamate release and a compensatory decrease in quantal content. J Neurosci 24:10466-10474. CrossRef Medline
20. De Gois S, Schäfer MK, Defamie N, Chen C, Ricci A, Weihe E, Varoqui H, Erickson JD (2005) Homeostatic scaling of vesicular glutamate and GABA transporter expression in rat neocortical circuits. J Neurosci 25: 7121-7133. CrossRef Medline
21. Dobrunz LE, Stevens CF (1997) Heterogeneity of release probability, facilitation, and depletion at central synapses. Neuron 18:995-1008. CrossRef Medline
22. Doyle S, Pyndiah S, De Gois S, Erickson JD (2010) Excitation-transcription coupling via calcium/calmodulin-dependent protein kinase/ERK1/2 signaling mediates the coordinate induction of VGLUT2 and Narp triggered by a prolonged increase in glutamatergic synaptic activity. J Biol Chem 285:14366-14376. CrossRef Medline
23. Dudek SM, Bear MF (1992) Homosynaptic long-term depression in area CA1of hippocampus and effects ofN-methyl-D-aspartate receptor blockade. Proc Natl Acad Sci U S A 89:4363-4367. CrossRef Medline
24. Dudek SM, Bear MF (1993) Bidirectional long-term modification of synap-tic effectiveness in the adult and immature hippocampus. J Neurosci 13:2910-2918. Medline
25. Edwards D, Berry JJ (1987) The efficiency of simulation-based multiple comparisons. Biometrics 43:913-928. CrossRef Medline
26. Ehninger D, Li W, Fox K, Stryker MP, Silva AJ (2008) Reversing neurode-velopmental disorders in adults. Neuron 60:950-960. CrossRef Medline
27. Erickson JD, De Gois S, Varoqui H, Schafer MK, Weihe E (2006) Activity-dependent regulation of vesicular glutamate and GABA transporters: a means to scale quantal size. Neurochem Int 48:643-649. CrossRef Medline
28. Fan N, Yang H, Zhang J, Chen C (2010) Reduced expression of glutamate receptors and phosphorylation of CREB are responsible for in vivo Delta9-THC exposure-impaired hippocampal synaptic plasticity. J Neu-rochem 112:691-702. CrossRef Medline
29. Farley FW, Soriano P, Steffen LS, Dymecki SM (2000) Widespread recom-binase expression using FLPeR (Flipper) mice. Genesis 28:106-110. CrossRef Medline
30. Feldmeyer D, Egger V, Lubke J, Sakmann B (1999) Reliable synaptic connections between pairs of excitatory layer 4 neurones within a single 'barrel' of developing rat somatosensory cortex. J Physiol 521:169-190. CrossRef Medline
31. Feldmeyer D, Lübke J, Silver RA, Sakmann B (2002) Synaptic connections between layer 4 spinay neuron-layer 2/3 pyramidal cell pairs in juvenile rat barrel cortex: physiology and anatomy of interlaminar signalling with a cortical column. J Physiol 538:803-822. CrossRef Medline
32. Ferraris D, Duvall B, Ko YS, Thomas AG, Rojas C, Majer P, Hashimoto K, Tsukamoto T (2008) Synthesis and biological evaluation of D-amino acid oxidase inhibitors. J Med Chem 51:3357-3359. CrossRef Medline
33. Fremeau RT Jr, Troyer MD, Pahner I, Nygaard GO, Tran CH, Reimer RJ, Bellocchio EE, Fortin D, Storm-Mathisen J, Edwards RH (2001) The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron 31:247-260. CrossRef Medline
34. Fremeau RT Jr, Voglmaier S, Seal RP, Edwards RH (2004a) VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate. Trends Neurosci 27:98-103. CrossRef Medline
35. Fremeau RT Jr, Kam K, Qureshi T, Johnson J, Copenhagen DR, Storm-Mathisen J, Chaudhry FA, Nicoll RA, Edwards RH (2004b) Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites. Science 304:1815-1819. CrossRef Medline
36. Fujiyama F, Furuta T, Kaneko T (2001) Immunocytochemical localization of candidates for vesicular glutamate transporters in the rat cerebral cortex. J Comp Neurol 435:379-387. CrossRef Medline
37. Goff DC, Tsai G, Manoach DS, Flood J, Darby DG, Coyle JT (1996) D-Cycloserine added to clozapine for patients with schizophrenia. Am J Psychiatry 153:1628-1630. Medline
38. Gonzalez-Burgos G, Kroener S, Zaitsev AV, Povysheva NV, Krimer LS, Bar-rionuevo G, Lewis DA (2008) Functional maturation of excitatory synapses in layer 3 pyramidal neurons during postnatal development of the primate prefrontal cortex. Cereb Cortex 18:626-637. CrossRef Medline
39. Gorski JA, Talley T, Qiu M, Puelles L, Rubenstein JL, Jones KR (2002) Cortical excitatory neurons and glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage. J Neurosci 22:6309-6314. Medline
40. Groc L, Petanjek Z, Gustafsson B, Ben-Ari Y, Hanse E, Khazipov R (2002) In vivo blockade of neural activity alters dendritic development of neonatal CA1 pyramidal cells. Eur J Neurosci 16:1931-1938. CrossRef Medline
41. Halasy K, Hajszan T, Kovács EG, Lam TT, Leranth C (2004) Distribution and origin of vesicular glutamate transporter 2-immunoreactive fibers in the rat hippocampus. Hippocampus 14:908-918. CrossRef Medline
42. Hall BJ, Ripley B, Ghosh A (2007) NR2B signaling regulates the development of synaptic AMPA receptor current. J Neurosci 27:13446-13456. CrossRef Medline
43. Hashimoto K, Fujita Y, Horio M, Kunitachi S, Iyo M, Ferraris D, Tsukamoto T (2009) Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine. Biol Psychiatry 65:1103-1106. CrossRef Medline
44. Herkenham M (1978) The connections of the nucleus reuniens thalami: evidence for a direct thalamo-hippocampal pathway in the rat. J Comp Neurol 177:589-610. CrossRef Medline
45. Herzog E, Bellenchi GC, Gras C, Bernard V, Ravassard P, Bedet C, Gasnier B, Giros B, El Mestikawy S (2001) The existence of a second vesicular glu-tamate transporter specifies subpopulations of glutamatergic neurons. J Neurosci 21:RC181. Medline
46. Herzog E, Takamori S, Jahn R, Brose N, Wojcik SM (2006) Synaptic and vesicular co-localization of the glutamate transporters VGLUT1 and VGLUT2 in the mouse hippocampus. J Neurochem 99:1011-1018. CrossRef Medline
47. Hsia AY, Malenka RC, Nicoll RA (1998) Development of excitatory circuitry in the hippocampus. J Neurophysiol 79:2013-2024. Medline
48. Javitt DC (2009) Glycine transport inhibitors for the treatment of schizophrenia: symptom and disease modification. Curr Opin Drug Discov Devel 12:468-478. Medline
49. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308. Medline
50. Jentsch JD, Roth RH (1999) The neuropsychopharmacology of phencycli-dine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20:201-225. CrossRef Medline
51. Jentsch JD, Trantham-Davidson H, Jairl C, Tinsley M, Cannon TD, Lavin A (2009) Dysbindin modulates prefrontal cortical glutamatergic circuits and working memory function in mice. Neuropsychopharmacology 34: 2601-2608. CrossRef Medline
52. Johnson JW, Ascher P (1987) Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325:529-531. CrossRef Medline
53. Johnston MV, Mullaney B, Blue ME (2003) Neurobiology of Rett syndrome. J Child Neurol 18:688-692. CrossRef Medline
54. Kaneko T, Fujiyama F (2002) Complementary distribution of vesicular glu-tamate transporters in the central nervous system. Neurosci Res 42:243-250. CrossRef Medline
55. Kemp A, Manahan-Vaughan D (2007) Hippocampal long-term depression: master or minion in declarative memory processes? Trends Neurosci 30: 111-118. CrossRef Medline
56. Keshavan MS, Anderson S, Pettegrew JW (1994) Is schizophrenia due to excessive synaptic pruning inthe prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatr Res 28:239-265. CrossRef Medline
57. Lee RY, Sawin ER, Chalfie M, Horvitz HR, Avery L (1999) EAT-4, a homolog of a mammalian sodium-dependent inorganic phosphate cotransporter, is necessary for glutamatergic neurotransmission in Caenorhabditis elegans. J Neurosci 19:159-167. Medline
58. Le Roux N, Amar M, Moreau A, Fossier P (2007) Involvement of NR2A- or NR2B-containing N-methyl-D-aspartate receptors in the potentiation of cortical layer 5 pyramidal neurone inputs depends on the developmental stage. Eur J Neurosci 26:289-301. CrossRef Medline
59. Lynch MA (2004) Long-term potentiation and memory. Physiol Rev 84:87-136. CrossRef Medline
60. Martina M, Gorfinkel Y, Halman S, Lowe JA, Periyalwar P, Schmidt CJ, Bergeron R (2004) Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels. J Physiol 557:489-500. CrossRef Medline
61. Milliken G, Johnson D (1984) Analysis of messy data, volume I: designed experiments, p 463. New York: Van Nostrand Reinhold.
62. Milner AJ, Cummings DM, Spencer JP, Murphy KP (2004) Bi-directional plasticity and age-dependent long-term depression at mouse CA3-CA1 hippocampal synapses. Neurosci Lett 367:1-5. CrossRef Medline
63. Minichiello L, Korte M, Wolfer D, Kühn R, Unsicker K, Cestari V, Rossi-Arnaud C, Lipp HP, Bonhoeffer T, Klein R (1999) Essential role for TrkB receptors in hippocampus-mediated learning. Neuron 24:401-414. CrossRef Medline
64. Mizuguchi H, Xu Z, Ishii-Watabe A, Uchida E, Hayakawa T (2000) IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther 1:376-382. CrossRef Medline
65. Modi ME, Young LJ (2011) D-Cycloserine facilitates socially reinforced learning in an animal model relevant to autism spectrum disorders. Biol Psychiatry 70:298-304. CrossRef Medline
66. Moechars D, Weston MC, Leo S, Callaerts-Vegh Z, Goris I, Daneels G, Buist A, Cik M, van der Spek P, Kass S, Meert T, D'Hooge R, Rosenmund C, Hampson RM (2006) Vesicular glutamate transporter VGLUT2 expression levels control quantal size and neuropathic pain. J Neurosci 26: 12055-12066. CrossRef Medline
67. Moghaddam B, Javitt D (2012) From revolution to evolution: The gluta-mate hypothesis of schizophrenia and its implication for treatment. Neu-ropsychopharmacology Rev 37:4-15. CrossRef Medline
68. Mohn AR, Gainetdinov RR, Caron MG, Koller BH (1999) Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98:427-436. CrossRef Medline
69. Monfils MH, Teskey GC (2004) Induction of long-term depression is associated with decreased dendritic length and spine density inlayers III and V of sensorimotor neocortex. Synapse 53:114-121. CrossRef Medline
70. Morris R (1984) Developmentsofawater-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47-60. CrossRef Medline
71. Moskal JR, Burgdorf J, Kroes RA, Brudzynski SM, Panksepp J (2011) A novel NMDA receptor glycine-site partial agonist, GLYX-13, has therapeutic potential for the treatment of autism. Neurosci Biobehav Rev 35: 1982-1988. CrossRef Medline
72. Moutsimilli L, Farley S, Dumas S, El Mestikawy S, Giros B, Tzavara ET (2005) Selective cortical VGLUT1 increaseasa marker for antidepressant activity. Neuropharmacology 49:890-900. CrossRef Medline
73. Moutsimilli L, Farley S, El Khoury MA, Chamot C, Sibarita JB, Racine V, El Mestikawy S, Mathieu F, Dumas S, Giros B, Tzavara ET (2008) Antip-sychotics increase vesicular glutamate transporter 2 (VGLUT2) expression in thalamolimbic pathways. Neuropharmacology 54:497-508. CrossRef Medline
74. Na ES, Nelson ED, Kavalali ET, Monteggia LM (2012) The impact of MeCP2 loss- or gain-of-function on synaptic plasticity. Neuropsychop-harmacology. Advance online publication. Retrieved July 11, 2012. doi: 10.1038/npp.2012.116. CrossRef Medline
75. Nägerl UV, Eberhorn N, Cambridge SB, Bonhoeffer T (2004) Bidirectional activity-dependent morphological plasticity in hippocampal neurons. Neuron 44:759-767. CrossRef Medline
76. Nakamura K, Watakabe A, Hioki H, Fujiyama F, Tanaka Y, Yamamori T, Kaneko T (2007) Transiently increased colocalization of vesicular glu-tamate transporters 1 and 2 at single axon terminals during postnatal development of mouse neocortex: a quantitative analysis with correlation coefficient. Eur J Neurosci 26:3054-3067. CrossRef Medline
77. Nakatani-Pawlak A, Yamaguchi K, Tatsumi Y, Mizoguchi H, Yoneda Y (2009) Neonatal phencyclidine treatment in mice induces behavioral, histological and neurochemical abnormalities in adulthood. Biol Pharm Bull 32:1576-1583. CrossRef Medline
78. Novak A, Guo C, Yang W, Nagy A, Lobe CG (2000) Z/EG,a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision. Genesis 28:147-155. CrossRef Medline
79. Oni-Orisan A, Kristiansen LV, Haroutunian V, Meador-Woodruff JH, Mc-Cullumsmith RE (2008) Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia. Biol Psychiatry 63:766-775. CrossRef Medline
80. Otmakhova NA, Otmakhov N, Lisman JE (2002) Pathway-specific properties of AMPA and NMDA-mediated transmission in CA1 hippocampal pyramidal cells. J Neurosci 22:1199-1207. Medline
81. Pan WX, McNaughton N (2004) The supramammillary area: its organization, functions and relationship to the hippocampus. Prog Neurobiol 74:127-166. CrossRef Medline
82. Penzes P, Cahill ME, Jones KA, VanLeeuwen JE, Woolfrey KM (2011) Dendritic spine pathology in neuropsychiatric disorders. Nat Neurosci 14: 285-293. CrossRef Medline
83. Prithviraj R, Inglis FM (2008) Expression of the N-methyl-D-aspartate receptor subunit NR3B regulates dendrite morphogenesis in spinal motor neurons. Neuroscience 155:145-153 (PMID:18541382). CrossRef Medline
84. Ramirez DM, Kavalali ET (2011) Differential regulationof spontaneous and evoked neurotransmitter release at central synapses. Curr Opin Neuro-biol 21:275-282. CrossRef Medline
85. Ramsey AJ (2009) NR1 knockdown mice as a representative model of the glutamate hypothesis of schizophrenia. Prog Brain Res 179:51-58. CrossRef Medline
86. Sakimura K, Kutsuwada T, Ito I, Manabe T, Takayama C, Kushiya E, Yagi T, Aizawa S, Inoue Y, Sugiyama H (1995) Reduced hippocampal LTP and spatial learningin mice lacking NMDA receptor epsilon1 subunit. Nature 373:151-155. CrossRef Medline
87. Schäfer MK, Varoqui H, Defamie N, Weihe E, Erickson JD (2002) Molecular cloning and functional identification of mouse vesicular glutamate transporter 3 and its expression in subsets of novel excitatory neurons. J Biol Chem 277:50734-50748. CrossRef Medline
88. Schwenk F, Baron U, Rajewsky K (1995) A cre-transgenic mouse strain for the ubiquitous deletion of LoxPflanked gene segments including deletion in germ cells. Nucleic Acids Res 23:5080-5081. CrossRef Medline
89. Shinoda Y, Tanaka T, Tominaga-Yoshino K, Ogura A (2010) Persistent synapse loss induced by repetitive LTD in developing rat hippocampal neurons. PLoS One 5:e10390. CrossRef Medline
90. Silva AJ, Ehninger D (2009) Adult reversal of cognitive phenotypes in neu-rodevelopmental disorders. J Neurodev Disord 1:150-157. CrossRef Medline
91. Skelton RW, McNamara RK (1992) Bilateral knife cuts to the perforant path disrupt spatial learning in the Morris water maze. Hippocampus 2:73-80. CrossRef Medline
92. Smith SE, Zhou YD, Zhang G, Jin Z, Stoppel DC, Anderson MP (2011) Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice. Sci Transl Med 3:103ra197. CrossRef Medline
93. Smith SM, Uslaner JM, Yao L, Mullins CM, Surles NO, Huszar SL, Mc-Naughton CH, Pascarella DM, Kandebo M, Hinchliffe RM, Sparey T, Brandon NJ, Jones B, Venkatraman S, Young MB, Sachs N, Jacobson MA, Hutson PH (2009) The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serine. J Pharmacol Exp Ther 328:921-930. CrossRef Medline
94. Smith SM, Uslaner JM, Hutson PH (2010) The therapeutic potential of D-amino acid oxidase (DAAO) inhibitors. Open Med Chem J 4:3-9. Medline
95. Sorensen SA, Rubel EW (2006) The level and integrity of synaptic input regulates dendrite structure. J Neurosci 26:1539-1550. CrossRef Medline
96. Sorensen SA, Rubel EW (2011) Relative input strength rapidly regulates dendritic stucture of chick auditory brainstem neurons. J Comp Neurol 519:2838-2851. CrossRef Medline
97. Soriano P (1999) Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21:70-71. CrossRef Medline
98. Speed HE, Dobrunz LE (2009) Developmental changes in short-term facilitation are opposite at temporammonic synapses compared to Schaffer collateral synapses onto CA1 pyramidal cells. Hippocampus 19:187-204. CrossRef Medline
99. Stefani MR, Moghaddam B (2005) Transient N-methyl-D-aspartate receptor blockade in early development causes lasting cognitive deficits relevant to schizophrenia. Biol Psychiatry 57:433-436. CrossRef Medline
100. Sybirska E, Davachi L, Goldman-Rakic PS (2000) Prominence of direct entorhinal-CA1 pathway activation in sensorimotor and cognitive tasks revealed by 2-DG functional mapping in nonhuman primate. J Neurosci 20:5827-5834. Medline
101. Takamori S, Rhee JS, Rosenmund C, Jahn R (2001) Identification of differentiation-associated brain-specific phosphate transporter as a second vesicular glutamate transporter (VGLUT2). J Neurosci 21:RC182. Medline
102. Tang YP, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M, Liu G, Tsien JZ (1999) Genetic enhancement of learning and memory in mice. Nature 401:63-69. CrossRef Medline
103. Thomson AM (2000) Facilitation, augmentation and potentiation at central synapses. Trends Neurosci 23:305-312. CrossRef Medline
104. Tordera RM, Pei Q, Sharp T (2005) Evidence for increased expression of the vesicular glutamate transporter, VGLUT1, by a course of antidepressant treatment. J Neurochem 94:875-883. CrossRef Medline
105. Tordera RM, Totterdell S, Wojcik SM, Brose N, Elizalde N, Lasheras B, Del Rio J (2007) Enhanced anxiety, depressive-like behaviour and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1). Eur JNeurosci 25:281-290. CrossRef Medline
106. Tsien JZ, Chen DF, Gerber D, Tom C, Mercer EH, Anderson DJ, Mayford M, Kandel ER, Tonegawa S (1996) Subregion- and cell type-restricted gene knockout in mouse brain. Cell 87:1317-1326. CrossRef Medline
107. +/PI transporter as a novel vesicular glutamate transporter expressed in a distinct set of glutamatergic synapses. JNeurosci 22:142-155. Medline
108. Wallen-Mackenzie A, Gezelius H, Thoby-Brisson M, Nygård A, Enjin A, Fujiyama F, Fortin G, Kullander K (2006) Vesicular glutamate transporter 2 is required for central respiratory rhythm generation but not for locomotor central pattern generation. J Neurosci 26:12294-12307. CrossRef Medline
109. Wallén-Mackenzie A, Nordenankar K, Fejgin K, Lagerström MC, Emilsson L, Fredriksson R, Wass C, Andersson D, Egecioglu E, Andersson M, Strand-berg J, Lindhe O, Schiöth HB, Chergui K, Hanse E, Långström B, Fredriksson A, Svensson L, Roman E, Kullander K (2009) Restricted cortical and amygdaloid removal of vesicular glutamate transporter 2 in preadolescent mice impacts dopaminergic activity and neuronal circuitry of higher brain function. J Neurosci 29:2238-2251. CrossRef Medline
110. Wang CC, Held RG, Chang SC, Delpire E, Ghosh A, Hall BJ (2011) A critical role for NMDA receptors containing the GluN2B subunit in cortical development and function. Neuron 72:789-805. CrossRef Medline
111. Wasling P, Hanse E, Gustafsson B (2004) Developmental changes in release properties ofthe CA3-CA1 glutamate synapse in rat hippocampus. J Neu-rophysiol 92:2714-2724. CrossRef Medline
112. Weston MC, Nehring RB, Wojcik SM, Rosenmund C (2011) Interplay between VGLUT isoforms and endophilin A1 regulates neurotransmitter release and short-term plasticity. Neuron 69:1147-1159. CrossRef Medline
113. Wilson NR, Kang J, Hueske EV, Leung T, Varoqui H, Murnick JG, Erickson JD, Liu G (2005) Presynaptic regulation of quantal size by the vesicular glutamate transporter VGLUT1. J Neurosci 25:6221-6234. CrossRef Medline
114. Wong RO, Ghosh A (2002) Activity-dependent regulation of dendritic growth and patterning. Nat Rev Neurosci 3:803-812. CrossRef Medline
115. Zoghbi HY (2003) Postnatal neurodevelopmental disorders: meeting at the synapse? Science 302:826-830. CrossRef Medline